Treatment And Prevention Of Heparin-Induced Thrombocytopenia
Publication Date: February 1, 2012
Last Updated: March 14, 2022
Recommendations
Screening for HIT
For patients receiving heparin in whom clinicians consider the risk of HIT to be >1%, we suggest that platelet count monitoring be performed every 2 or 3 days from day 4 to day 14 (or until heparin is stopped, whichever occurs first). (2, C)
307795
Title
Treatment And Prevention Of Heparin-Induced Thrombocytopenia
Authoring Organization
American College of Chest Physicians